Variant report

Variant	nsv882505
Chromosome Location	chr5:101397849-101652251
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr5:101551961-101552911	HepG2	liver:	n/a	chr5:101552035-101552051
2	ARID3A	chr5:101631937-101632405	HepG2	liver:	n/a	n/a
3	ARID3A	chr5:101489024-101489385	HepG2	liver:	n/a	n/a
4	ARID3A	chr5:101558223-101559288	HepG2	liver:	n/a	n/a
5	ARID3A	chr5:101559542-101559874	HepG2	liver:	n/a	n/a
6	ARID3A	chr5:101426566-101426872	HepG2	liver:	n/a	n/a
7	ARID3A	chr5:101435321-101436198	HepG2	liver:	n/a	n/a
8	ARID3A	chr5:101473945-101474313	HepG2	liver:	n/a	n/a
9	ATF2	chr5:101631952-101632369	GM12878	blood:	n/a	n/a
10	BACH1	chr5:101631034-101631692	H1-hESC	embryonic stem cell:	n/a	n/a
11	BACH1	chr5:101631923-101632496	H1-hESC	embryonic stem cell:	n/a	n/a
12	BATF	chr5:101553848-101554117	GM12878	blood:	n/a	chr5:101553951-101553960
13	BCLAF1	chr5:101631938-101632474	GM12878	blood:	n/a	chr5:101632362-101632375 chr5:101632257-101632270 chr5:101632046-101632054 chr5:101632261-101632274
14	BHLHE40	chr5:101558583-101558831	HepG2	liver:	n/a	n/a
15	BHLHE40	chr5:101567506-101567776	GM12878	blood:	n/a	n/a
16	BHLHE40	chr5:101435342-101436124	HepG2	liver:	n/a	n/a
17	BHLHE40	chr5:101435704-101436031	HepG2	liver:	n/a	n/a
18	BHLHE40	chr5:101435606-101436058	HepG2	liver:	n/a	n/a
19	BHLHE40	chr5:101473978-101474432	HepG2	liver:	n/a	n/a
20	BHLHE40	chr5:101631948-101632297	HepG2	liver:	n/a	n/a
21	BHLHE40	chr5:101558455-101558904	HepG2	liver:	n/a	n/a
22	BHLHE40	chr5:101553984-101554248	HepG2	liver:	n/a	n/a
23	BHLHE40	chr5:101631890-101632399	GM12878	blood:	n/a	n/a
24	BRCA1	chr5:101559586-101559705	H1-hESC	embryonic stem cell:	n/a	n/a
25	CCNT2	chr5:101518922-101519122	K562	blood:	n/a	n/a
26	CEBPB	chr5:101440285-101440515	H1-hESC	embryonic stem cell:	n/a	chr5:101440390-101440401
27	CEBPB	chr5:101474104-101474393	HepG2	liver:	n/a	chr5:101474303-101474316 chr5:101474305-101474316 chr5:101474303-101474316 chr5:101474303-101474314 chr5:101474303-101474316
28	CEBPB	chr5:101577620-101577902	HepG2	liver:	n/a	chr5:101577760-101577771
29	CEBPB	chr5:101474093-101474484	HepG2	liver:	n/a	chr5:101474303-101474316 chr5:101474305-101474316 chr5:101474303-101474316 chr5:101474303-101474314 chr5:101474303-101474316
30	CEBPB	chr5:101431550-101431869	HepG2	liver:	n/a	chr5:101431724-101431735
31	CEBPB	chr5:101558556-101558984	MCF-7	breast:	n/a	chr5:101558770-101558781 chr5:101558772-101558783
32	CEBPB	chr5:101634828-101635028	A549	lung:	n/a	chr5:101634861-101634872
33	CEBPB	chr5:101574944-101575157	HepG2	liver:	n/a	n/a
34	CEBPB	chr5:101558645-101559090	A549	lung:	n/a	chr5:101558770-101558781 chr5:101559037-101559050 chr5:101559039-101559050 chr5:101558772-101558783
35	CEBPB	chr5:101574945-101575095	A549	lung:	n/a	n/a
36	CEBPB	chr5:101459346-101459437	H1-hESC	embryonic stem cell:	n/a	n/a
37	CEBPB	chr5:101558486-101559039	HepG2	liver:	n/a	chr5:101558770-101558781 chr5:101558772-101558783
38	CEBPB	chr5:101492747-101492947	HepG2	liver:	n/a	n/a
39	CEBPB	chr5:101452184-101452476	HepG2	liver:	n/a	chr5:101452316-101452327
40	CEBPB	chr5:101440224-101440561	HepG2	liver:	n/a	chr5:101440390-101440401
41	CEBPB	chr5:101607434-101607866	HepG2	liver:	n/a	n/a
42	CEBPB	chr5:101474058-101474421	HepG2	liver:	n/a	chr5:101474303-101474316 chr5:101474305-101474316 chr5:101474303-101474316 chr5:101474303-101474314 chr5:101474303-101474316
43	CEBPB	chr5:101558524-101558873	HepG2	liver:	n/a	chr5:101558770-101558781 chr5:101558772-101558783
44	CEBPB	chr5:101634700-101635037	HepG2	liver:	n/a	chr5:101634861-101634872
45	CEBPB	chr5:101620494-101620741	H1-hESC	embryonic stem cell:	n/a	n/a
46	CEBPB	chr5:101552558-101552836	HepG2	liver:	n/a	n/a
47	CEBPB	chr5:101552538-101552742	HepG2	liver:	n/a	n/a
48	CEBPB	chr5:101440235-101440558	A549	lung:	n/a	chr5:101440390-101440401
49	CEBPB	chr5:101619217-101619371	A549	lung:	n/a	chr5:101619311-101619324 chr5:101619311-101619322 chr5:101619311-101619324
50	CEBPB	chr5:101440324-101440475	K562	blood:	n/a	chr5:101440390-101440401

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:101632559-101632609	BJ	skin:	n/a
2	chr5:101425870-101425920	HRCEpiC	kidney:	n/a
3	chr5:101632559-101632609	BJ	skin:	n/a
4	chr5:101425870-101425920	HRCEpiC	kidney:	n/a
5	chr5:101633158-101633208	HEEpiC	esophagus:	n/a
6	chr5:101632321-101632371	NB4	blood:	n/a
7	chr5:101570551-101570601	HIPEpiC	eye:	n/a
8	chr5:101632050-101632100	GM12891	blood:	n/a
9	chr5:101632341-101632391	AG09319	gingival:	n/a
10	chr5:101552551-101552601	HUVEC	blood vessel:	n/a
11	chr5:101632286-101632336	NB4	blood:	n/a
12	chr5:101632314-101632364	PANC-1	pancreas:	n/a
13	chr5:101632372-101632422	GM12892	blood:	n/a
14	chr5:101570551-101570601	MCF-7	breast:	n/a
15	chr5:101570551-101570601	HUVEC	blood vessel:	n/a
16	chr5:101632286-101632336	GM06990	blood:	n/a
17	chr5:101632050-101632100	PFSK-1	brain:	n/a
18	chr5:101632372-101632422	HPAEpiC	pulmonary alveolar:	n/a
19	chr5:101632050-101632100	IMR90	lung:	fetal
20	chr5:101632321-101632371	GM12891	blood:	n/a
21	chr5:101632327-101632377	AG04450	lung:	fetal
22	chr5:101632341-101632391	ProgFib	skin:	n/a
23	chr5:101632171-101632221	PANC-1	pancreas:	n/a
24	chr5:101631505-101631555	BJ	skin:	n/a
25	chr5:101632314-101632364	HL-60	blood:	n/a
26	chr5:101634495-101634545	PFSK-1	brain:	n/a
27	chr5:101552551-101552601	AoSMC	blood vessel:	n/a
28	chr5:101631505-101631555	SAEC	small airway:	n/a
29	chr5:101632559-101632609	SK-N-SH_RA	brain:	n/a
30	chr5:101632372-101632422	NHDF-neo	bronchial:	n/a
31	chr5:101632286-101632336	HEK293	kidney:	embryo
32	chr5:101552551-101552601	NHBE	bronchial:	n/a
33	chr5:101634495-101634545	HAEpiC	amniotic membrane:	n/a
34	chr5:101631668-101631718	LNCaP	prostate:	n/a
35	chr5:101631668-101631718	U87	brain:	n/a
36	chr5:101425870-101425920	HAEpiC	amniotic membrane:	n/a
37	chr5:101632050-101632100	HMEC	breast:	n/a
38	chr5:101632501-101632551	NHDF-neo	bronchial:	n/a
39	chr5:101631668-101631718	A549	lung:	n/a
40	chr5:101632321-101632371	HPAEpiC	pulmonary alveolar:	n/a
41	chr5:101632372-101632422	RPTEC	kidney:	n/a
42	chr5:101632372-101632422	PrEC	prostate:	n/a
43	chr5:101632171-101632221	IMR90	lung:	fetal
44	chr5:101631505-101631555	Jurkat	blood:	n/a
45	chr5:101632501-101632551	HAEpiC	amniotic membrane:	n/a
46	chr5:101632341-101632391	LNCaP	prostate:	n/a
47	chr5:101632372-101632422	GM12891	blood:	n/a
48	chr5:101633158-101633208	HUVEC	blood vessel:	n/a
49	chr5:101632501-101632551	GM12878	blood:	n/a
50	chr5:101552551-101552601	AG09309	skin:	n/a

No.	Distal block	Cell Line	Cell type
1	chr5:101277703..101278961-chr5:101426537..101427100,3	MCF-7	breast:
2	chr5:101476598..101478204-chr5:101481147..101483100,2	MCF-7	breast:
3	chr5:101277636..101278379-chr5:101489093..101489664,2	MCF-7	breast:
4	chr5:101432287..101434879-chr5:101435908..101438270,2	K562	blood:
5	chr5:98439759..98440660-chr5:101559209..101559794,3	K562	blood:
6	chr5:101626744..101629663-chr5:101630622..101633299,2	MCF-7	breast:
7	chr17:62222226..62225133-chr5:101631590..101633345,2	MCF-7	breast:
8	chr5:101475498..101477506-chr5:101479656..101481283,2	K562	blood:
9	chr5:101432287..101434879-chr5:101435908..101438270,2	K562	blood:
10	chr5:100977296..100978177-chr5:101426469..101427113,2	MCF-7	breast:
11	chr5:101435579..101437280-chr5:101437849..101439350,2	MCF-7	breast:
12	chr5:101312840..101313801-chr5:101426237..101427126,3	MCF-7	breast:
13	chr5:101277790..101278635-chr5:101488732..101489585,4	MCF-7	breast:
14	chr5:101476598..101478204-chr5:101481147..101483100,2	MCF-7	breast:
15	chr5:101435579..101437280-chr5:101437849..101439350,2	MCF-7	breast:
16	chr5:101277581..101278499-chr5:101426192..101427059,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-PAM-5	chr5:101482018-101482276	NONHSAT103022
2	lnc-PAM-5	chr5:101479780-101479847	NONHSAT103022
3	lnc-PAM-7	chr5:101638208-101638514	NONHSAT103024
4	lnc-PAM-5	chr5:101479781-101479847	XLOC_004491
5	lnc-PAM-5	chr5:101482019-101482276	XLOC_004491

Variant related genes	Relation type
ENSG00000248261	TF binding region
RN7SKP68	TF binding region
SLCO4C1	TF binding region
RNA5SP188	TF binding region
ENSG00000268424	TF binding region
ENSG00000248261	CpG island
RN7SKP68	CpG island
SLCO4C1	CpG island
RNA5SP188	CpG island
ENSG00000268424	CpG island
ENSG00000266402	chromatin interactions
ENSG00000199753	chromatin interactions
ENSG00000248261	chromatin interactions
ENSG00000173930	chromatin interactions

Extended variants
information (count: 6313 )
Associated
traits (count: 88 )

Variant overlapped rSNPs/rCNVs (count:6313 , 50 per page) page: 1 2 3 4 5 6 7 ... 127

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs140668279	chr5:101400618-101400619	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs34486312	chr5:101400660-101400661	Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs567895343	chr5:101400662-101400663	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs577700148	chr5:101400664-101400665	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs368960091	chr5:101400687-101400688	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs145836359	chr5:101400692-101400693	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs373438327	chr5:101400694-101400695	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs59704374	chr5:101400700-101400701	Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs138268552	chr5:101400726-101400727	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs181345630	chr5:101400749-101400750	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs557345009	chr5:101400789-101400790	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs10479123	chr5:101400797-101400798	Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs540397154	chr5:101401007-101401008	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs111365884	chr5:101401040-101401041	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs112296335	chr5:101401119-101401120	Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs529625309	chr5:101401409-101401410	Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs547808604	chr5:101401429-101401430	Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs142971301	chr5:101401479-101401480	Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs147484579	chr5:101401484-101401485	Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs188417158	chr5:101401507-101401508	Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs182297780	chr5:101401527-101401528	Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs542806860	chr5:101401548-101401549	Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs557483352	chr5:101401558-101401559	Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs370036218	chr5:101401571-101401572	Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs569410714	chr5:101401621-101401622	Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs34996801	chr5:101401623-101401624	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs34660431	chr5:101401643-101401644	Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs371038055	chr5:101401660-101401661	Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs187412831	chr5:101401666-101401667	Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs573060923	chr5:101401687-101401688	Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs540167575	chr5:101401696-101401697	Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs78427408	chr5:101401761-101401762	Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs191804449	chr5:101401783-101401784	Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs369002368	chr5:101401803-101401804	Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs181506142	chr5:101401821-101401822	Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs562219543	chr5:101401835-101401836	Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs139935397	chr5:101401845-101401846	Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs541390051	chr5:101401919-101401920	Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs72776129	chr5:101401974-101401975	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs528736290	chr5:101402036-101402037	Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs185886888	chr5:101402123-101402124	Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs190005738	chr5:101402170-101402171	Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs532737434	chr5:101402185-101402186	Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs143909155	chr5:101402202-101402203	Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs559704889	chr5:101402252-101402253	Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs569347014	chr5:101402272-101402273	Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs150784064	chr5:101402304-101402305	Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs17145871	chr5:101402346-101402347	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs566759020	chr5:101402351-101402352	Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs370653026	chr5:101402376-101402377	Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:88)

Disease	PMID	Source
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Metanephric adenoma	20802469	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Cancer	16751803	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	17603634	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Melanoma	18172304	CNVD
Glioma	20126413	CNVD
Breast cancer	17393978	CNVD
Cancer	21359685	CNVD
Non-small cell lung cancer	21829676	CNVD
adenomatous polyposis	22470819	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Breast cancer	21858162	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
Lung cancer	18438408	CNVD
Retinoblastoma	22278416	CNVD
Bipolar disorder	18458673	CNVD
Thyroid cancer	19087340	CNVD
Breast cancer	21785460	CNVD
Merkel cell carcinoma	19020549	CNVD
Squamous cell cancer	20885788	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	22521361	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	17133270	CNVD
Acute myeloid leukemia	20729466	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Acute myeloid leukemia	21251322	CNVD
lymphocytic leukemia	21291569	CNVD
Testicular cancer	18059402	CNVD
Colorectal cancer	16272173	CNVD
Prostate cancer	16573809	CNVD
Renal cell carcinoma	18194544	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Cancer	20164920	CNVD
Myelodysplastic syndrome	21251322	CNVD
abnormal development	18461090	CNVD
Myelofibrosis	22110671	CNVD
Colorectal cancer	16774939	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Multiple myeloma	17550852	CNVD
Glioblastoma multiforme	22286061	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Ovarian cancer	21720365	CNVD
Prostate cancer	16461572	CNVD
Neurocytoma	17123091	CNVD
Salivary gland tumor	18059337	CNVD
Breast cancer	21509527	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Schizophrenia	23813976	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:917 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:101400600-101400800	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
2	chr5:101401000-101401200	Enhancers	Gastric	stomach
3	chr5:101401400-101403000	Enhancers	Fetal Intestine Large	intestine
4	chr5:101401600-101403000	Enhancers	Fetal Intestine Small	intestine
5	chr5:101402800-101403400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
6	chr5:101403400-101404200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
7	chr5:101405000-101405600	Enhancers	HUES48 Cell Line	embryonic stem cell
8	chr5:101405400-101405600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
9	chr5:101405400-101405800	Enhancers	iPS-15b Cell Line	embryonic stem cell
10	chr5:101405600-101407000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
11	chr5:101413200-101413800	Enhancers	Pancreas	Pancrea
12	chr5:101414400-101415000	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
13	chr5:101414800-101416600	Enhancers	HepG2	liver
14	chr5:101421200-101421400	Enhancers	Fetal Intestine Small	intestine
15	chr5:101421400-101423400	Weak transcription	Fetal Intestine Small	intestine
16	chr5:101423400-101423600	Enhancers	Fetal Intestine Large	intestine
17	chr5:101423400-101423600	Enhancers	Fetal Intestine Small	intestine
18	chr5:101423600-101424200	Weak transcription	Fetal Intestine Large	intestine
19	chr5:101423600-101424400	Weak transcription	Fetal Intestine Small	intestine
20	chr5:101424200-101425800	Enhancers	Fetal Intestine Large	intestine
21	chr5:101424400-101425000	Enhancers	Fetal Intestine Small	intestine
22	chr5:101424800-101425800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
23	chr5:101424800-101426600	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
24	chr5:101425000-101425400	Enhancers	H1 Cell Line	embryonic stem cell
25	chr5:101425000-101425400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
26	chr5:101425000-101425800	Enhancers	iPS-15b Cell Line	embryonic stem cell
27	chr5:101425000-101426400	Weak transcription	Fetal Intestine Small	intestine
28	chr5:101425000-101426800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
29	chr5:101425200-101425600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
30	chr5:101425200-101425800	Enhancers	HUES64 Cell Line	embryonic stem cell
31	chr5:101425200-101426000	Enhancers	Breast Myoepithelial Primary Cells	Breast
32	chr5:101425200-101426600	Enhancers	iPS-18 Cell Line	embryonic stem cell
33	chr5:101425200-101426800	Enhancers	HUES48 Cell Line	embryonic stem cell
34	chr5:101425800-101426200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
35	chr5:101425800-101426800	Weak transcription	HUES64 Cell Line	embryonic stem cell
36	chr5:101426000-101426400	Weak transcription	Breast Myoepithelial Primary Cells	Breast
37	chr5:101426200-101427000	Enhancers	iPS-15b Cell Line	embryonic stem cell
38	chr5:101426400-101426600	Enhancers	Breast Myoepithelial Primary Cells	Breast
39	chr5:101426400-101426600	Enhancers	Fetal Intestine Small	intestine
40	chr5:101426600-101434000	Weak transcription	Breast Myoepithelial Primary Cells	Breast
41	chr5:101426800-101427000	Enhancers	HUES64 Cell Line	embryonic stem cell
42	chr5:101426800-101431200	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
43	chr5:101431200-101432000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
44	chr5:101432000-101437000	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
45	chr5:101434000-101434200	Enhancers	Breast Myoepithelial Primary Cells	Breast
46	chr5:101434000-101435400	Enhancers	HepG2	liver
47	chr5:101434200-101434800	Weak transcription	Breast Myoepithelial Primary Cells	Breast
48	chr5:101434200-101437600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
49	chr5:101435200-101437400	Enhancers	Fetal Intestine Small	intestine
50	chr5:101435400-101435800	Flanking Active TSS	HepG2	liver

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links